4//SEC Filing
Tardio Jason 4
Accession 0001209191-22-049938
CIK 0001636651other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:58 PM ET
Size
4.9 KB
Accession
0001209191-22-049938
Insider Transaction Report
Form 4
Tardio Jason
Chief Commercial Officer
Transactions
- Sale
Common Stock
2022-09-12$2.15/sh−17,344$37,290→ 0 total
Footnotes (1)
- [F1]The Reporting Person acquired the shares pursuant to the Issuer's employee stock purchase plan. These transactions were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Following the reported transaction, the Reporting Person will hold no ESPP shares.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001794698
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 4:58 PM ET
- Size
- 4.9 KB